Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?

被引:68
作者
Castellani, RJ
Smith, MA
Nunomura, A
Harris, PLR
Perry, G
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[2] Univ Maryland, Dept Pathol, Div Neuropathol, Baltimore, MD 21201 USA
[3] Asahikawa Med Coll, Dept Psychiat & Neurol, Asahikawa, Hokkaido 078, Japan
关键词
Alzheimer disease; amyloid-beta; ceruloplasmin; copper; free radicals; iron; neurofibrillary tangles; oxidative stress; senile plaques;
D O I
10.1016/S0891-5849(99)00016-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the most striking features of Alzheimer disease (AD) is an accumulation of iron in neurofibrillary tangles and senile plaques. Intriguingly, this iron is found as both iron (II) and iron (III) and is redox-active. To address the issue of whether such iron participates in redox cycling, it was essential to investigate how iron (II) accumulates, since oxidation of iron (II) can lead to the generation of reactive oxygen species. To begin to address this issue, here we investigated ceruloplasmin, a key protein involved in the regulation of the redox state of iron by converting iron (II) to iron (III). Cases of AD and age-matched controls, obtained at autopsy with similar postmortem intervals, display similar levels of ceruloplasmin immunoreactivity that is mainly confined to neurons. However, in marked contrast, cases of AD show a significant increase in ceruloplasmin within the neuropil determined by immunoblot analysis of tissue homogenates as well as a generalized increased neuropil staining. Together, these findings suggest that neuronal induction of ceruloplasmin is feeble in AD, even while there is an increase in tissue ceruloplasmin. Therefore, a failure of neuronal ceruloplasmin to respond to iron may be an important factor that then leads to an accumulation of redox-active iron in neurons in AD. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:1508 / 1512
页数:5
相关论文
共 41 条
[1]  
ADRIAN GS, EXP CELL RES, V186, P385
[2]   THE CEREBRAL EXPRESSION OF PLASMA-PROTEIN GENES IN DIFFERENT SPECIES [J].
ALDRED, AR ;
BRACK, CM ;
SCHREIBER, G .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1995, 111 (01) :1-15
[3]   WILSON DISEASE [J].
BREWER, GJ ;
YUZBASIYANGURKAN, V .
MEDICINE, 1992, 71 (03) :139-164
[4]   AN ELECTRON-PARAMAGNETIC-RES STUDY OF THE NON-EQUIVALENCE OF THE COPPER SITES OF CERULOPLASMIN [J].
CALABRESE, L ;
CARBONARO, M .
BIOCHEMICAL JOURNAL, 1986, 238 (01) :291-295
[5]   CERULOPLASMIN LEVELS IN THE HUMAN SUPERIOR TEMPORAL GYRUS IN AGING AND ALZHEIMERS-DISEASE [J].
CONNOR, JR ;
TUCKER, P ;
JOHNSON, M ;
SNYDER, B .
NEUROSCIENCE LETTERS, 1993, 159 (1-2) :88-90
[6]   A HISTOCHEMICAL-STUDY OF IRON, TRANSFERRIN, AND FERRITIN IN ALZHEIMERS DISEASED BRAINS [J].
CONNOR, JR ;
MENZIES, SL ;
STMARTIN, SM ;
MUFSON, EJ .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 31 (01) :75-83
[7]   FERRITIN AND CERULOPLASMIN IN OXIDATIVE DAMAGE - REVIEW AND RECENT FINDINGS [J].
DESILVA, DM ;
AUST, SD .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1993, 71 (09) :715-720
[8]  
GOLDSTEIN IM, 1979, J BIOL CHEM, V254, P4040
[9]  
Good PF, 1996, AM J PATHOL, V149, P21
[10]  
Harris E D, 1993, Prog Clin Biol Res, V380, P163